Tandem Diabetes Care, Inc. announced on May 10, 2024, the company and Unomedical a/s entered into Amendment Number 1 (Amendment 1) to the Distributor Agreement, dated as of January 14, 2022, between the Company and Unomedical, under which Unomedical manufactures, tests, sterilizes and packs all of the infusion sets under the Company?s brands (the Original Agreement). Under Amendment 1, the term of the Original Agreement is extended, and certain definitions and terms and conditions related to distributorship, additional products, manufacturing, labeling, product specifications, purchase commitments and other matters are amended.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.83 USD | -0.40% | -9.55% | +44.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.79% | 2.77B | |
-3.19% | 105B | |
-4.14% | 67.55B | |
+15.49% | 46.71B | |
-6.00% | 46.39B | |
+4.82% | 40.93B | |
+22.10% | 31.63B | |
+12.18% | 24.28B | |
-8.53% | 23.46B | |
-12.33% | 21.95B |
- Stock Market
- Equities
- TNDM Stock
- News Tandem Diabetes Care, Inc.
- Tandem Diabetes Care, Inc. and Unomedical a/s Enter into Amendment Number 1 to Distributor Agreement